Research map: Efficacy and Safety of the Extemporaneous Combination Nebivolol/Amlodipine in Patients with Hypertension Uncontrolled on Monotherapy: The BOTTICELLI Study

Back to the article

Papers in this map

  1. 2018 ESC/ESH Guidelines for the management of arterial hypertension · Bryan Williams · 2018 · 10595 citations · Cited by this paper
  2. Inflammaging and Cardiovascular Risk in Old Women · 2025 · Related
  3. The global epidemiology of hypertension · Katherine T. Mills · 2020 · 4240 citations · Cited by this paper
  4. Pregnancy as a Window for Hypertension and Cardiovascular Prevention in Women: A Life-Course Perspective Based on the 2025 ESC Guidelines · 2026 · Related
  5. Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants · Bin Zhou · 2021 · 3947 citations · Cited by this paper
  6. Impaired Intracranial Compliance: A New Hypertension-Mediated Brain Organ Damage? · 2026 · Related
  7. 2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension · Giuseppe Mancia · 2023 · 3398 citations · Cited by this paper
  8. Trends and Projections in Hypertension-Related Mortality in the United States: A 1979–2050 CDC WONDER Analysis · 2025 · Related
  9. 2024 ESC Guidelines for the management of elevated blood pressure and hypertension · John William McEvoy · 2024 · 2312 citations · Cited by this paper
  10. Lipoprotein(a) in Essential Hypertension: Associations with Blood Pressure and Hypertension-Mediated Organ Damage · 2026 · Related
  11. A Review of Nebivolol Pharmacology and Clinical Evidence · Justin Fongemie · 2015 · 127 citations · Cited by this paper
  12. Associations of the Triglyceride-Glucose Index and Body Fat Composition with Blood Pressure in Children and Adolescents · 2025 · Related
  13. Nebivolol: A Highly Selective β1‐Adrenergic Receptor Blocker That Causes Vasodilation by Increasing Nitric Oxide · Sandeep Gupta · 2008 · 103 citations · Cited by this paper
  14. Assessment of Triglyceride/High-Density Lipoprotein Cholesterol Ratio and Triglyceride-Glucose Index Threshold in Patients with Chronic Kidney Disease: Evaluation of Clinical Features and Outcomes · 2025 · Related
  15. Effects of blood pressure-lowering treatment on cardiovascular outcomes and mortality · Costas Thomopoulos · 2018 · 92 citations · Cited by this paper
  16. Burden of Cardiovascular Diseases Attributable to Hypertension in Population Aged 60 Years or Older from 1990 to 2040 across BRICS-plus Countries (Egypt, Ethiopia, Iran, Saudi Arabia, United Arab Emirates, Brazil, Russia, India, China, and South Africa) · 2025 · Related
  17. Clinical pharmacodynamics of nebivolol: new evidence of nitric oxide‐mediated vasodilating activity and peculiar haemodynamic properties in hypertensive patients · Alberto Zanchetti · 2004 · 86 citations · Cited by this paper
  18. Dapagliflozin Reduces Ambulatory Arterial Stiffness Index in CKD Patients with and Without Diabetes Independently of Blood Pressure Control: Results from the GLUcose Transport and Renal PROtection in Chronic Kidney Disease (GLUTREPRO) Trial · 2025 · Related
  19. Amlodipine in the current management of hypertension · Ji‐Guang Wang · 2023 · 70 citations · Cited by this paper
  20. Abdominal Aorta Remodeling in Hypertensive Patients: The Campania Salute Network · 2025 · Related
  21. Nebivolol · Otto Kamp · 2009 · 60 citations · Cited by this paper
  22. Combined effects of hypertension, hyperlipidemia, and diabetes mellitus on the presence and severity of carotid atherosclerosis in community-dwelling elders: A community-based study · Shu-Xin Lu · 2022 · 46 citations · Cited by this paper
  23. Central blood pressure for the management of hypertension: Is it a practical clinical tool in current practice? · Hao‐Min Cheng · 2019 · 45 citations · Cited by this paper
  24. Amlodipine improves endothelial function and metabolic parameters in patients with hypertension · Kwang Kon Koh · 2008 · 35 citations · Cited by this paper
  25. Combining Other Antihypertensive Drugs With β-Blockers in Hypertension: A Focus on Safety and Tolerability · Tiffany R. Richards · 2014 · 34 citations · Cited by this paper
  26. Therapeutic Properties of Highly Selective β-blockers With or Without Additional Vasodilator Properties: Focus on Bisoprolol and Nebivolol in Patients With Cardiovascular Disease · Waleed AlHabeeb · 2021 · 32 citations · Cited by this paper
  27. A Critical Review of Nebivolol and its Fixed-Dose Combinations in the Treatment of Hypertension · Arrigo F.G. Cicero · 2018 · 21 citations · Cited by this paper
  28. The Role of Nebivolol in the Management of Hypertensive Patients: From Pharmacological Profile to Treatment Guidelines · Claudio Ferri · 2021 · 21 citations · Cited by this paper
  29. A growing evidence base for the fixed-dose combination of bisoprolol and amlodipine to manage hypertension · Ulrike Gottwald‐Hostalek · 2022 · 10 citations · Cited by this paper
  30. Real-world efficacy and safety of nebivolol in Korean patients with hypertension from the BENEFIT KOREA study · Jinho Shin · 2019 · 9 citations · Cited by this paper
  31. Effect of nebivolol monotherapy or combination therapy on blood pressure levels in patients with hypertension: an updated systematic review and multilevel meta-analysis of 91 randomized controlled trials · Athanasios Manolis · 2024 · 6 citations · Cited by this paper
  32. Combination therapy with nebivolol/amlodipine is superior to metoprolol/amlodipine in the control of cuff and 24-hr ambulatory blood pressure · Henry A. Punzi · 2015 · 5 citations · Cited by this paper
  33. Comparison of Effect of Nebivolol and Bisoprolol on Sexual Function of Hypertensive Female Patients · Nomesh Kumar · 2021 · 5 citations · Cited by this paper
  34. Effect of Amlodipine/Nebivolol combination therapy on central BP and PWV compared to Amlodipine/Valsartan combination therapy · El-Zahraa M. Sultan · 2022 · 5 citations · Cited by this paper
  35. Efficacy and safety of bisoprolol 5 mg plus amlodipine 5 mg in patients with hypertension uncontrolled on monotherapy with 5 mg of amlodipine, a phase III multicenter, randomized, double-blind, placebo-controlled clinical trial – the AMCOR study · Piotr Jędrusik · 2023 · 5 citations · Cited by this paper
  36. Editorial – New European ESH and ESC guidelines for the management of hypertension: More similarities than differences · Guido M. Grassi · 2024 · 4 citations · Cited by this paper
  37. Extemporaneous combination therapy with nebivolol/amlodipine for the treatment of hypertension: a real-world evidence study in Europe · Giovambattista Desideri · 2024 · 3 citations · Cited by this paper

Source: OpenAlex (CC0)